“…The extensive use of conventional antibiotics makes bacteria more resistant, and hence the number of drug-resistant bacterial strains is ever increasing . Therefore, there is an urgent need to design and develop alternative antibacterial agents with high antibacterial efficacy and bacterial strain selectivity. , In this respect, the rapid development of nanomaterial-based antibiotics opens up a new avenue to solve the bacterial resistant problem. , To date, there are several kinds of nanomaterials, such as gold nanoparticles, silver nanoparticles, graphene-based materials, peptides, etc., that have been explored for their high antibacterial activity but with limited bacterial strain selectivity. − Although there are various nanomaterial-based antibiotics reported, there is always a need to develop novel nanomaterials with efficient antibacterial activity, specifically with selectivity …”